论文信息 - Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial - 字舞流文

Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial

M. Einstein | R. Sperling | F. Struyf | G. Dubin | M. David | J. Lalezari | N. Chakhtoura | M. Blatter | A. Chatterjee | P. Takacs | Lan Lin